Supplementary Figure 9 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Supplemental Figure 9A demonstrates the overlap between "p53-associated" signature from Troester et al. vs. "p53-like" signature from Choi et al; Supplemental Figure 9B shows the "p53-like" signature from Choi et (MDA) by UROMOL Subclasses in MSK and UNC cohorts; and Supplemental Figure 9C shows the "p53-associated" signature from Troester et al. by UROMOL Subclasses in MSK and UNC cohorts.